Pace Logo

FDA Regulatory Consulting

Professional Services / Regulatory and Compliance / FDA Regulatory Consulting

Advancing Therapeutics Through Pivotal Regulatory Affairs Approvals

Maintain progress as your program reaches pivotal regulatory stages by engaging our experts to identify, prepare, and submit the appropriate materials to regulators. We provide expert insights on the best pathways forward to ensure adequate funding and technical support. With drug development being such an extensive, detail-oriented process, partnering with world-class regulatory affairs consultants helps safeguard your progress and maintain efficiency.

Ready To Get Started?
Or Call: 612.656.1175

Pharmaceutical Regulatory Affairs Services

Our understanding of the domestic and international regulatory challenges facing biotech and pharmaceutical operations enables our experts to provide comprehensive support across the drug development pipeline.

Pace Scientist working in laboratory. FDA regulatory consultants, FDA regulatory consulting, FDA regulatory consultant, Regulatory affairs consultant, Pharmaceutical regulatory affairs, Pharmaceutical Regulatory Consulting, Pharmaceutical Regulatory Affairs Consulting, Pharmaceutical Regulatory Affairs Services
Regulatory Strategy

Leverage our expertise in drug development for pharmaceuticals, biologics, gene therapies and drug-device combination products. Our team has extensive knowledge in the US and EU regulations.

  • Regulatory Advisory Consulting
  • Gap Analysis
  • Feasibility Assessment
  • CMC Consulting
Designations And Expedited Programs

Determine the best path forward for your therapeutic or device. Our consultants provide insights to guide you through designations that support your program.

  • Orphan Drug Designation and Annual Reports (FDA and EMA)
  • Rare Pediatric Disease Designation
  • Regenerative Medicine Advanced Therapy Designation
  • Qualified Infectious Disease Product Designation
  • Expedited Programs
  • ○ Fast Track Designation
  • ○ Breakthrough Therapy Designation
Interactions With Agency

Be ready for your engagement with regulatory agencies such as the FDA and EMA. From developing regulatory strategy and authoring meeting requests/briefing packages to meeting preparation and attendance, we provide the level of support you need.

  • Formal Meetings with FDA Type A, B, C, D
  • Pre-IND Meeting
  • End of Phase 2 (EOP2) Meeting
  • Pre-NDA Meeting / Pre-BLA Meeting
  • INTERACT Meeting
IND Authoring

Garner in-depth guidance for your regulatory applications, including authoring of regulatory documents and in-house publishing capabilities. Our team of experts provide full writing and publishing support as well as content, QC, and formatting review.

  • Authoring Regulatory Documents
  • Investigational New Drug Application (IND)
  • Biologic License Application (BLA)
  • New Drug Application (NDA)
  • 505(b)(2) NDA Application
eCTD Publishing

Submit your regulatory documents to the FDA Electronic Submission Gateway (ESG) portal with confidence. We support application preparation including document compilation, metadata hyperlinking, lifecycle management, and technical validation.

  • Initial INDs
  • Annual Reports and/or Development Safety Update Reports (DSUR)
  • Meeting Requests and Briefing Packages
  • CMC Amendments and Protocol Amendments
  • Safety Reporting

Regulatory Affairs Resources

eCTD-Compliant Publishing & Submissions

How Consulting Firms Assist the IND Process

FDA Orphan Drug Designation

Keeping Pace® with Pharma

Discover unique insights to meet milestones, achieve regulatory compliance, and relieve internal constraints.

Integrated Laboratory Services  

When your team needs additional support, we are ready to jump in to meet demand. Our diverse range of regulatory experts allows us to aid in a variety of projects and programs.